Literature DB >> 9559404

Tuberculosis patients and practitioners in private clinics in India.

M Uplekar1, S Juvekar, S Morankar, S Rangan, P Nunn.   

Abstract

SETTING: Rural and urban areas of Maharashtra, a large state in Western India.
OBJECTIVE: To understand tuberculosis (TB) management practices among private medical practitioners (PPs) and the treatment behaviour of the patients they manage.
DESIGN: Prospective study of help-seeking patterns and treatment behaviour among 173 pulmonary TB patients diagnosed in private clinics, and the TB management practices of 122 PPs treating these patients.
RESULTS: The first source of help for 86% of patients was a PP. The diagnostic and treatment practices of PPs were inadequate; 15% did not consider sputum examination to be necessary, and 79 different treatment regimens were prescribed by 105 reporting PPs. Sixty-seven percent of the patients diagnosed in private clinics remained with the private sector, and the rest shifted to public health services within six months of treatment. The treatment adherence rate among the patients in private clinics was 59%. There were discrepancies between the reported management practices of the PPs and what their patients actually followed.
CONCLUSION: The study identifies and highlights the need to educate PPs and their TB patients, and indicates ways in which PPs could be meaningfully involved in efforts to revitalize the national TB control programme.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559404

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  65 in total

1.  The DOTs strategy. More than just watching patients take their tablets.

Authors:  A Fanning
Journal:  West J Med       Date:  1999-07

2.  Public and private providers' quality of care for tuberculosis patients in Kampala, Uganda.

Authors:  L Nshuti; D Neuhauser; J L Johnson; F Adatu; C C Whalen
Journal:  Int J Tuberc Lung Dis       Date:  2001-11       Impact factor: 2.373

3.  Private health care in developing countries.

Authors:  A B Zwi; R Brugha; E Smith
Journal:  BMJ       Date:  2001-09-01

4.  Alternative medicine: an ethnographic study of how practitioners of Indian medical systems manage TB in Mumbai.

Authors:  Andrew McDowell; Madhukar Pai
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-03       Impact factor: 2.184

Review 5.  Improving tuberculosis control through public-private collaboration in India: literature review.

Authors:  Puneet K Dewan; S S Lal; Knut Lonnroth; Fraser Wares; Mukund Uplekar; Suvanand Sahu; Reuben Granich; Lakhbir Singh Chauhan
Journal:  BMJ       Date:  2006-02-08

6.  Engaging private providers and Ayurvedic practitioners in Bilaspur, India: did it increase TB case detection?

Authors:  R R Bhardwaj; J E Oeltmann; C Ravichandra; V K Chadda; M Das; A M V Kumar
Journal:  Public Health Action       Date:  2016-06-21

7.  Impact of a Structured Tuberculosis Awareness Strategy on the Knowledge and Behaviour of the Families in a Slum Area in Chhattisgarh, India.

Authors:  Janmejaya Samal; Ranjit Kumar Dehury
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.

Authors:  V Balaji; Peter Daley; Alok Azad Anand; Thambu Sudarsanam; Joy Sarojini Michael; Rani Diana Sahni; Poorvi Chordia; Ige Abraham George; Kurien Thomas; Alka Ganesh; K R John; Dilip Mathai
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

9.  Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study.

Authors:  Ted Cohen; Bethany L Hedt; Marcello Pagano
Journal:  BMC Public Health       Date:  2010-06-21       Impact factor: 3.295

10.  High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.

Authors:  Desiree T B D'souza; Nerges F Mistry; Tina S Vira; Yatin Dholakia; Sven Hoffner; Geoffrey Pasvol; Mark Nicol; Robert J Wilkinson
Journal:  BMC Public Health       Date:  2009-06-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.